Member Info for scotlouie

i have no clue whats going on and if its a true reflection onto uk market sp. i havent traded the germany marlets before looking at the below posts and looking into all markets AEG is traded on gives surprising results;

https://markets.ft.com/data/equities/tearsheet/summary?s=BZHA:FRA

BERLIN- up 125% finishing at EUR 0.09

great, keep us posted on any useful info from it, id like to hear your views after it

im not saying it cant be as early as march researcher but Q2 is april onwards so i wouldnt expect it to come early since its the first of its kind the FDA will want to go through the submission and data completely before their decision and may even aso for additional information/data but hopefully our extensive application has all the relevant data that they need, hence why im giving it a few more weeks to get an official answer. but im happy whenever it comes to be honest. like others whos followed AGL over the years... weeks isnt an issue weeks-months so be it. but within 6months its looking very strong for approval news and then the growth begins with partnerships and sales contracts.

do you know if they will be publishing notes online after this conference? be interesting to see and hear about the response from this.

40p support has held up well against the selling pressure of late and struggled to break on 3 attempts so its safe to safe that the 40p is. the current bottom and would like to see some more support gaining into the new year. news could come anytime and even as early as april so not too long a wait. im still thinking more towards the end of Q2 so wnd of may-june. into the new year as long as that 40p support doesnt break i see positiona being taken and a nice climb into the 60-80p range pre FDA news. that would be an ideal position pre news as that RNS should gap up and have a good trading day with high volume. but by that time youve already miss the initial rise from these levels. The BB is nice and quiet with it flying under the radar. will get busier with the rainbow chasers so will see the FDA rns and try pump AGL up to high heavens sprouting out nonsense but im ok with that lol. ill sit back and let them try and drive it up. all of the LTHs should be happy and in a good position. unless your in the red and got a big paper loss which should recover in next few months all going well

so you think they can only deliver a couple 900T coalswitch contracts a few times a year?

i see no reason why that couldnt be achieved after FDA approval and US interest in sales pick up. add that along with a possible US listing next year its primed for a takeover target.

id be happy with £4 ;)

Morgank whats strange is the declared shareholdings were crossed on 1st dec. it still doesnt explain the huge 32M volume day we had a couple days after that. almost 15% of all of AGLs shares traded in one day!! still goes unexplained.

i cant see a low ball offer going through also. i do believe AGL will get bought out but when at what price i have no idea. it will most certainly be after FDA approval as the big pharmas wont be willing to risk capital before the red tape has been cut. then they might be wanting to forward a buyout. obv the longer they leace it the bigger the price will be if parsortix is sucessful (i see no reason why it wouldnt be)

even at a low ball offerr of £2 is many multiples of current sp but in my opinion that wont go through. im not one to get some pie in the sky figures id much rather company do their thing and let it progress naturally. either way im happy when FFA approval has been given. by that stage id like to see sp over £1

Br3xiUK im a little bewildered by your post. although i always stand by that a chat board has to have both positive and negative views to balance on your thought process on holding, buying and also selling a stock. I always welcome this rather than the mindless ramping and deramping that plagues all stock boards (when volume is there) but your comment about chasing money. isnt this the real reasom why anyone buys any stock on the stock market? to make a profit greater than what a bank offers on interest? if it wasnt the case why invest at all? stick it in a bank and collect interest. for ones who dont care about profit then why not invest in charities? give money to good causes? some invest purely on financial gain others may back the company due to personal circumstances, e.g. someone in their family dealt with cancer and would like to help others in the future hence backing the company via buying stock.

i dont udnerstand your other comment on pandemic hype. this has nothing to do with covid or any treatments to do with it. why would AGL benefit from it? although sp doesnt truley reflex a fair value for AGL in my eyes but this has mainly been due to the FDA procedure and delays caused from covid related restrictions, like the clinicial studies and patient enrolement being stopped from lockdown restrictions. jupiter have sold millions of shares for whatever reason has hammered the price and had a constant selling pressure on the sp. without big news coming out these shares havent been absored from the main market yet as weve seen a few ii's have been happy to pay 40-45p for the stock flushing out jupiter(or possibly flushing them out completely).

i agree that there isnt any ground breaking news until FDA aporoval which isnt until next year, but if theres buyers out there this will rerate due to being oversold for several weeks-months of constanst selling pressure from jupiter.

just came across a proactive post. decent background info if your new to AGL

https://www.proactiveinvestors.co.uk/companies/news/211923/angles-parsortix-liquid-biopsy-proving-to-be-more-than-just-a-cancer-detection-device-211923.html

nice find Morgank. now we know whos been buying then! healthy amount of shares now not in the public hands

double bottom 40p reversal seems to be holding, nice climb to 45p over coming days might be the signal needed for a reversal. reckon a few are waiting for either confirmation jupiter are out or confirmation reversal is now in play. which should result in a sharp upwards swing possible back into the 50s

might be too early to predict but maybe bottoms been found at 40p!

chimers i was under the impression they would still need to declare their holding above 3%. (or 5% if thats the rule for ii's)

I'm amazed that there's not been a TR-1 released with the amount of volume we have had over the past weeks. the volume has been huge and yet no buyer has declared their holding. the volume has been the biggest in the past month or two in all of AGL history although we know Jupiter has been selling and possibly near out completely we still have no idea whos been snapping up the transferred shares.

strange!!! but when it pops i wont really be caring!! on a plus side 40p seems to be holding and may create a double bottom here which isnt a bad thing for all those techie charty wiz kids out there ;)

that study will not be completed in Q1 2021. the enrolement for this will be completed in Q2 2021 so around the same time as FDA approval. there was delays involved for enrollment due to corona and lockdowns. enrollment was put on hold and started back up in june following restrictions hence the delay. details can be found in half year and yearly results. after enrollement has been completed in Q2 then will be several weeks-months after they have the data for this study and complete it. was benefit us is after FDA approval is gained for breast cancer then it is a pretty straight forward process for submitting for FDA approval on ovarian and follow up cancers. we will not have the similar timeframe and should be fast tracked with the data supplied from the ovarian studies.

hi chester you asked about potential roll out systems of the parsortix. it was mentioned in the recent investors presentation found at:

https://m.youtube.com/watch?v=X-ux25RcGw4

at 13:27 mins into the presentation Andrew explains how parsortix can be rolled out after FDA approval. multiple revenue streams in the form of;

pharma- R&D drives new applications
Pharma- large scale research use, drug trails,
LDTs- laboratory tests
clinical products- sales within hospitals.

a lot in the pipeline purely on the breast cancer then soon after ovarian cancer (along with prostate, brain and any other cancer types)

as for how quickly they can meet demand is a difficult one to answer as its down to obtaining the sales contracts but so far Andrew/BODs havent gave the feel they cant cope with this increased prpduction. its built into their stradegy to ramp up

there's two coming at least... jupiter below 3% and whoever the new buyer has been. with the trades today alone will cross that threshold. never mind the trades previous to allow jupiter to shift all those other millons.

the breaks were let off at mid day today signalling jupiter shares have dried up. big question would be is the new buyer happy with a swap of ownership from jupiter or are they still hungry for more on the open market.

https://tools.morningstar.co.uk/uk/stockreport/default.aspx?tab=0&vw=st&SecurityToken=0P00007NXK%5D3%5D0%5DE0WWE%24%24ALL&Id=0P00007NXK&ClientFund=0&CurrencyId=BAS

whos up for a good week next week? monday morning holding RNS then lift off?

now theyre flooding in. i see them now

its safe to say Jupiter has left the building!!!

Morgank 32.65M? where do you see that? im seeing 9.2M volume with a huge 2.7M delayed trade popping up at 17:07